American Academy of Child and Adolescent Psychiatry
2014 Psychopharmacology Update Institute
Treating the Refractory Patient: Adding Expertise to Evidence-Based Methods
Chairs: Laurence L. Greenhill, M.D. and Jean A. Frazier, M.D.
Institute Goals and Overview
In the past year, the media has been busy documenting the risks of psychopharmacological treatments for children and adolescence, such as diversion of stimulant medications, overuse of second generation antipsychotics in foster children, abuse of prescription medications, and metabolic syndrome developing in preschoolers treated with psychiatric medications. At the same time, questions have arisen about the practice of continuation of psychopharmacological treatments in non-responsive children and adolescents who have been refractory to all types of interventions by child and adolescent psychiatrists. This Institute reviews and updates participants about the possible medical and non-medical factors that lead to lack of treatment response and methods to detect and manage such factors.